Dominique Leroux Selected Research

Dominique Leroux Research Topics

Disease

9	Neoplasms (Cancer) 01/2016 - 06/2002
5	Lymphoma (Lymphomas) 01/2016 - 02/2003
4	Breast Neoplasms (Breast Cancer) 01/2020 - 04/2015
4	Melanoma (Melanoma, Malignant) 10/2011 - 08/2007
2	Genetic Predisposition to Disease (Genetic Predisposition) 12/2013 - 12/2009
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2013 - 02/2003
2	Parkinson Disease (Parkinson's Disease) 12/2009 - 08/2007
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2006 - 02/2003
1	Hodgkin Disease (Hodgkin's Disease) 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Leukemia 01/2016
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2016
1	Li-Fraumeni Syndrome 12/2013
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2013
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 09/2012
1	Kidney Neoplasms (Kidney Cancer) 10/2011
1	Hypoxia (Hypoxemia) 10/2011
1	Carcinogenesis 10/2011
1	Endometrial Neoplasms (Endometrial Cancer) 06/2011
1	Ovarian Neoplasms (Ovarian Cancer) 06/2011
1	Genetic Translocation (Chromosomal Translocation) 05/2010
1	Cutaneous Malignant Melanoma 07/2008
1	Hematologic Neoplasms (Hematological Malignancy) 08/2005
1	Hematologic Diseases (Blood Diseases) 08/2003
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2003
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2003
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2003
1	Necrosis 11/2002

Drug/Important Bio-Agent (IBA)

3	Biological ProductsIBA 01/2016 - 08/2003
3	Proteins (Proteins, Gene)FDA Link 08/2013 - 02/2003
2	Rituximab (Mabthera)FDA Link 08/2013 - 02/2003
2	Levodopa (L Dopa)FDA LinkGeneric 12/2009 - 08/2007
1	Estrogen ReceptorsIBA 01/2020
1	Oral ContraceptivesIBA 04/2018
1	Untranslated RNA (Noncoding RNA)IBA 01/2016
1	Calcibiotic Root Canal SealerIBA 01/2016
1	Long Noncoding RNAIBA 01/2016
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2015
1	Estrogens (Estrogen)FDA Link 04/2015
1	ChromatinIBA 12/2013
1	Monoclonal AntibodiesIBA 08/2013
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 09/2012
1	Mutant Proteins (Protein, Mutant)IBA 10/2011
1	Microphthalmia-Associated Transcription FactorIBA 10/2011
1	1,3- dihydroxy- 4,4,5,5- tetramethyl- 2- (4- carboxyphenyl)tetrahydroimidazole (NOR 1)IBA 06/2011
1	Satellite DNA (Satellite DNAs)IBA 05/2010
1	Cell Cycle ProteinsIBA 07/2008
1	Cyclin-Dependent Kinase Inhibitor p16IBA 07/2008
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 07/2008
1	NucleotidesIBA 08/2007
1	Histocompatibility Antigens Class IIBA 11/2006
1	trichostatin A (A 300)IBA 08/2005
1	Histone Deacetylase InhibitorsIBA 08/2005
1	Histone Deacetylases (Histone Deacetylase)IBA 08/2005
1	HeterochromatinIBA 08/2005
1	Caspase 8 (Caspase-8)IBA 03/2004
1	Fas-Associated Death Domain Protein (Fas-Associating Protein with Death Domain)IBA 03/2004
1	HLA-DR Antigens (HLA-DR)IBA 08/2003
1	Complement System Proteins (Complement)IBA 02/2003
1	Interferon-gamma (Interferon, gamma)IBA 11/2002
1	Interleukin-10 (Interleukin 10)IBA 11/2002
1	CD56 AntigenIBA 06/2002

Therapy/Procedure

5	Therapeutics 01/2016 - 08/2007
2	Immunotherapy 01/2018 - 11/2006
1	Drug Therapy (Chemotherapy) 08/2013
1	Ligation 07/2008